Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Протена Биосайенсис ЛимитедfiledCriticalПротена Биосайенсис Лимитед
Priority claimed from PCT/US2020/017357external-prioritypatent/WO2020163817A1/en
Publication of EA202192113A1publicationCriticalpatent/EA202192113A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
В изобретении предложены антитела, которые специфически связывают тау. Антитела по изобретению ингибируют или задерживают развитие патологий, ассоциированных с тау, и ассоциированного с ними ухудшения симптоматики.The invention provides antibodies that specifically bind tau. Antibodies of the invention inhibit or delay the development of tau-associated pathologies and the associated worsening of symptoms.
EA202192113A2019-05-312020-02-07
ANTIBODIES RECOGNIZING TAU
EA202192113A1
(en)